Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hulme

Showing results (181-190 of 192) with videos related to

Pageof 20
Sort By:
Bioorganic & Medicinal Chemistry|July 31, 1999
Benzofuran based PDE4 inhibitorsD G McGarry, J R Regan, F A Volz, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 12, 2018
IntAct: intra-operative fluorescence angiography to prevent anastomotic leak in rectal cancer surgery: a randomized controlled trialG Armstrong, J Croft, N Corrigan, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 26, 2018
Randomized controlled feasibility trial of supported self-management in adults with Type 2 diabetes mellitus and an intellectual disability: OK DiabetesA House, L Bryant, A M Russell, et al.
Journal of Dentistry|July 5, 2014
A randomised controlled trial of complete denture impression materialsT P Hyde, H L Craddock, J C Gray, et al.
BMJ Open|August 23, 2015
Community IntraVenous Antibiotic Study (CIVAS): protocol for an evaluation of patient preferences for and cost-effectiveness of community intravenous antibiotic servicesC Czoski Murray, M Twiddy, D Meads, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 13, 2022
Guilty by dissociation: Part A: Development of a rapid Ultra-High Performance Liquid Chromatography (UHPLC)-MS/MS methodology for the analysis of regioisomeric diphenidine-derived Novel Psychoactive Substances (NPS)Jennifer K Field, Christine Hinz, Christopher M Titman, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Dyrk1a inhibition with the Novel Compound DYR533: A Cross-Disease Therapeutic Strategy Targeting Amyloidosis, Tau Pathogenesis, and NeuroinflammationS K Bartholomew, J Turk, W Winslow, et al.
Translational Psychiatry|July 26, 2017
The DCDC2 deletion is not a risk factor for dyslexiaT S Scerri, E Macpherson, A Martinelli, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 27, 2012
Selecting breast cancer patients for chemotherapy: the opening of the UK OPTIMA trialJ Bartlett, P Canney, A Campbell, et al.
ACS Omega|June 11, 2019
Rapid Identification of Novel Psychoactive and Other Controlled Substances Using Low-Field <sup>1</sup>H NMR SpectroscopyLysbeth H Antonides, Rachel M Brignall, Andrew Costello, et al.
Pageof 20

Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
Bioorganic & Medicinal Chemistry|July 31, 1999
Benzofuran based PDE4 inhibitorsD G McGarry, J R Regan, F A Volz, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 12, 2018
IntAct: intra-operative fluorescence angiography to prevent anastomotic leak in rectal cancer surgery: a randomized controlled trialG Armstrong, J Croft, N Corrigan, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 26, 2018
Randomized controlled feasibility trial of supported self-management in adults with Type 2 diabetes mellitus and an intellectual disability: OK DiabetesA House, L Bryant, A M Russell, et al.
Journal of Dentistry|July 5, 2014
A randomised controlled trial of complete denture impression materialsT P Hyde, H L Craddock, J C Gray, et al.
BMJ Open|August 23, 2015
Community IntraVenous Antibiotic Study (CIVAS): protocol for an evaluation of patient preferences for and cost-effectiveness of community intravenous antibiotic servicesC Czoski Murray, M Twiddy, D Meads, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 13, 2022
Guilty by dissociation: Part A: Development of a rapid Ultra-High Performance Liquid Chromatography (UHPLC)-MS/MS methodology for the analysis of regioisomeric diphenidine-derived Novel Psychoactive Substances (NPS)Jennifer K Field, Christine Hinz, Christopher M Titman, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Dyrk1a inhibition with the Novel Compound DYR533: A Cross-Disease Therapeutic Strategy Targeting Amyloidosis, Tau Pathogenesis, and NeuroinflammationS K Bartholomew, J Turk, W Winslow, et al.
Translational Psychiatry|July 26, 2017
The DCDC2 deletion is not a risk factor for dyslexiaT S Scerri, E Macpherson, A Martinelli, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 27, 2012
Selecting breast cancer patients for chemotherapy: the opening of the UK OPTIMA trialJ Bartlett, P Canney, A Campbell, et al.
ACS Omega|June 11, 2019
Rapid Identification of Novel Psychoactive and Other Controlled Substances Using Low-Field <sup>1</sup>H NMR SpectroscopyLysbeth H Antonides, Rachel M Brignall, Andrew Costello, et al.
Pageof 20